跳至主要内容
临床试验/NCT03934788
NCT03934788已完成不适用

A Prospective Randomized Controlled Study to Evaluate the Clinical Performance of OxySoft Silicone Hydrogel Soft Contact Lens

Visco Vision Inc.6 个研究点 分布在 1 个国家目标入组 36 人开始时间: 2018年9月26日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
36
试验地点
6
主要终点
Log MAR visual acuities

研究概览

简要总结

The objective of this study is to demonstrate that the OxySoft silicone hydrogel soft contact lens could be prescribed as a supportive care for myopes.

详细描述

This is a double blind randomized control study to evaluate a daily disposable contact lens. It is planned to have 30 evaluable subjects at least divided evenly among 3 independent PIs. Each PI will enroll 12 subjects at least. The ration of evaluable test subjects to control subjects will be 2 to 1. The study lens will be dispensed randomly to subjects who have normal ocular health and conform to a set of criteria. It is necessary to wear the lens 8 hours a day and 5 days a week at least and follow up for one month (30 days). Data will be collected at baseline, 1 week, 2 week and 4 week of daily disposable modality including Adverse Reactions, Slit-lamp findings and Symptoms, Problems, and Complaints, vision acuity, keratometry change and reason for discontinuation.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
20 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subject should have normal eye and use no ocular medications
  • VA correctable to 0.1 LogMAR or better, with spherical lenses ranging in power from -1.00 to -10.00 D myopia, astigmatism =< 2.00 D
  • Willing to comply with all study procedures and be available for the duration of the study.
  • Provide signed and dated informed consent form.

排除标准

  • Subjects have history of allergies that would contraindicate "normal" contact lens wear.
  • Subjects have other active ocular or systemic disease such as, but not limited to: anterior uveitis (past or present), glaucoma, Sjögren's syndrome, lupus erythematosus, sclerodermas, keratoconus or type II diabetes, slip lamp findings greater than grade I (such as cornea or interstitial edema).
  • Subjects have medications that would contraindicate contact lens wear.
  • The presence of clinically significant (grade 3 or 4) anterior segment abnormalities; inflammations such as iritis; or any infection of the eye, lids, or associated structures.
  • A known history of corneal hypoesthesia (reduced corneal sensitivity), corneal ulcer, corneal infiltrates or fungal infections.
  • A history of papillary conjunctivitis that has interfered with contact lens wear.
  • Any active participation in another clinical trial within 30 days prior to this study.
  • Have had any cornea surgery.
  • Currently pregnant (to the best of the subject's knowledge), is lactating or is planning a pregnancy within the next 1 month.
  • Monocular or monovision fits
  • Alcoholic or Drug Abused.

研究组 & 干预措施

Oxysoft

Experimental

olifilcon C, daily disposable soft contact lens, 1 month

干预措施: oxysoft (olifilcon C) (Device)

SiHy

Active Comparator

olifilcon B, dialy disposable soft contact lens, 1 month

干预措施: Si-Hy (olifilcon B) (Device)

结局指标

主要结局

Log MAR visual acuities

时间窗: 1 month

The primary efficacy will be Log MAR visual acuities (VA) of 0.1 or better.

次要结局

  • slit lamp findings(1 month)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (6)

Loading locations...

相似试验